Percentage of responders between Treatments A and B for the Intent-To-Treat (ITT) population Last day of Periods 1 (Days 16-17) and 2 (Days 25-26) [clinicaltrials_resource:44eb38f9fe1d67ec34c353b91128bead]
30% or greater reduction in 24-hour stool volume from baseline
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Percentage of responders between Treatments A and B for the Intent-To-Treat (ITT) population Last day of Periods 1 (Days 16-17) and 2 (Days 25-26) [clinicaltrials_resource:44eb38f9fe1d67ec34c353b91128bead]
30% or greater reduction in 24-hour stool volume from baseline
Bio2RDF identifier
44eb38f9fe1d67ec34c353b91128bead
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:44eb38f9fe1d67ec34c353b91128bead
measure [clinicaltrials_vocabulary:measure]
Percentage of responders betwe ...... tent-To-Treat (ITT) population
time frame [clinicaltrials_vocabulary:time-frame]
Last day of Periods 1 (Days 16-17) and 2 (Days 25-26)
description
30% or greater reduction in 24-hour stool volume from baseline
identifier
clinicaltrials_resource:44eb38f9fe1d67ec34c353b91128bead
title
Percentage of responders betwe ...... Days 16-17) and 2 (Days 25-26)
@en
type
label
Percentage of responders betwe ...... b38f9fe1d67ec34c353b91128bead]
@en